Conjugation of Multiple Proteins Onto the Surface of PLGA/Lipid Hybrid Nanoparticles
Open Access
- 17 October 2024
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 113 (1)
Abstract
Nanoparticles are increasingly being used in the development of vaccines for disease prevention or treatment. Recent research has demonstrated that conjugating a protein onto the surface of nanoparticles can significantly increase its immunogenicity. Considering various pathogens that threaten human health, multivalent vaccines are often desirable. Up to now, nanoparticle‐based vaccines are mostly limited to one protein per nanoparticle. No research has been conducted to explore the possibility of conjugating more than one protein onto the surface of a nanoparticle. Here we developed a specific conjugation strategy to conjugate multiple proteins to the PLGA/lipid hybrid nanoparticle surface. The maleimide‐thiol Michael addition, Aizde‐DBCO (Dibenzocyclooctyne), and TCO (trans‐cycloctene)‐Tetrazine click chemistry were employed to conjugate three different proteins, subunit keyhole limpet hemocyanin (sKLH), Ovalbumin (OVA), and cross‐reactive material 197 (CRM197), to the surface of PLGA/lipid hybrid nanoparticles (hNPs). The successful results of this study pave the way for developing multivalent vaccines against different pathogens.Keywords
Funding Information
- National Institutes of Health
- National Institute on Drug Abuse (UG3DA048775)
- Virginia Polytechnic Institute and State University
This publication has 49 references indexed in Scilit:
- Investigation of the Immunogenic Properties of Ovalbumin Modified by Urban Airborne Particulate MatterArchivum Immunologiae et Therapiae Experimentalis, 2023
- Covid‐19 vaccines and variants of concern: A reviewReviews in Medical Virology, 2021
- Recent advances in liposome formulations for breast cancer therapeuticsCellular and Molecular Life Sciences, 2021
- Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: A focus on hapten densityBiomaterials, 2017
- The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccineBiomaterials, 2016
- Engineering the lipid layer of lipid–PLGA hybrid nanoparticles for enhanced in vitro cellular uptake and improved stabilityActa Biomaterialia, 2015
- Defined Conjugation of Glycans to the Lysines of CRM197 Guided by their Reactivity MappingChemBioChem, 2014
- PLGA/Liposome Hybrid Nanoparticles for Short-Chain Ceramide DeliveryPharmaceutical Research, 2013
- Vaccines and Immunogen Conjugates2013
- Keyhole limpet haemocyanin (KLH): Purification of intact KLH1 through selective dissociation of KLH2Micron, 1995